Published in Immunology on July 01, 1994
miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer. Sci Rep (2016) 0.82
The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells. J Exp Clin Cancer Res (2012) 0.80
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med (1989) 15.15
IL-10 inhibits cytokine production by activated macrophages. J Immunol (1991) 13.13
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol (1991) 10.58
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (1990) 7.15
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods (1980) 6.44
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med (1990) 4.30
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol (1990) 3.55
Interleukin-10. Curr Opin Immunol (1992) 2.85
Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor. J Exp Med (1993) 2.49
The locomotor capacity of human lymphocytes and its enhancement by cell growth. Immunology (1986) 1.59
Cytokine expression by germinal center cells. J Immunol (1993) 1.44
Antigen-induced locomotor responses in lymphocytes. J Exp Med (1977) 1.42
Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors. J Immunol (1989) 1.37
Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol (1993) 1.31
Requirement for macrophages or for macrophage- or T cell-derived factors in the mitogenic stimulation of murine B lymphocytes by lipopolysaccharides. Eur J Immunol (1983) 1.14
Induction of CD43 expression during activation and terminal differentiation of human B cells. Scand J Immunol (1988) 1.13
Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes. Immunology (1989) 0.97
T and B cell collaboration: induction of motility in small, resting B cells by interleukin 4. Eur J Immunol (1991) 0.91
Lymphokine control of type 2 antigen response. IL-10 inhibits IL-5- but not IL-2-induced Ig secretion by T cell-independent antigens. J Immunol (1992) 0.89
IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23. Int Immunol (1993) 0.87
Activation of normal human B cells through their antigen receptor induces membrane expression of IL-1 alpha and secretion of IL-1 beta. J Immunol (1989) 0.86
Locomotion and chemotaxis of leukocytes: gradient perception and locomotor capacity. Curr Opin Immunol (1989) 0.84
Interleukin 4 induces cellular adhesion among B lymphocytes. Growth Factors (1989) 0.84
A visual study of chemotaxis of human lymphocytes using a collagen-gel assay. J Immunol Methods (1985) 0.83
The polyclonal lipopolysaccharide response is accessory-cell-dependent. Scand J Immunol (1983) 0.80
Regulatory effect of antibody on the immune response. Adv Immunol (1968) 6.03
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Thymus-independent B-cell induction and paralysis. Adv Immunol (1975) 3.27
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology (1994) 2.61
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet (1995) 2.43
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
Frequency of antigen-sensitive cells to thymus-independent antigens. Cell Immunol (1971) 2.39
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro. Nature (1965) 2.12
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. Clin Exp Immunol (1969) 2.03
Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. Cell Immunol (1972) 1.93
Studies at the cellular level of the 19S immune response. Acta Pathol Microbiol Scand (1966) 1.93
Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol (1974) 1.87
Persistence of immunogenicity of two complex antigens retained in vivo. Immunology (1968) 1.87
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells. Eur J Immunol (1972) 1.81
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem (1984) 1.77
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. J Immunol (1972) 1.73
Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol (1970) 1.71
T cell growth factor abrogates concanavalin A-induced suppressor cell function. J Exp Med (1981) 1.68
In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol (1973) 1.62
Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature (1981) 1.61
Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators. Scand J Immunol (1974) 1.57
Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) (1998) 1.56
The effector cell in antibody-induced cell mediated immunity. Transplant Rev (1973) 1.56
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
Requirement for adherent cells in the primary and secondary immune response in vitro. Eur J Immunol (1972) 1.51
Immunological unresponsiveness to thymus-independent antigens: two fundamentally different genetic mechanisms of B-cell unresponsiveness to dextran. J Exp Med (1977) 1.50
Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. Cell Immunol (1972) 1.48
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors. J Exp Med (1974) 1.46
Suppressive effect of graft versus host reactions on the immune response to heterologous red cells. Immunology (1971) 1.45
Induction of DNA synthesis in human lymphocytes: interaction between non-specific mitogens and antigens. Immunology (1970) 1.45
Prolonged survival of H-2 incompatible skin allografts on F1 animals treated with parental lymphoid cells. Immunology (1969) 1.44
Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol (1990) 1.44
Regulation of cellular antibody synthesis. Cellular 7S production and longevity of 7S antigen-sensitive cells in the absence of antibody feedback. J Exp Med (1968) 1.42
Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells. J Exp Med (1973) 1.39
Lymphocytic responses to streptococcal antigens in glomerulonephritic patients. Science (1970) 1.39
CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med (1997) 1.38
The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol (2004) 1.37
One non-specific signal triggers b lymphocytes. Transplant Rev (1975) 1.36
Characterization of self-reactive B cells by polyclonal B-cell activators. J Exp Med (1977) 1.34
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
In vitro induction of specific immune responses in the absence of serum: requirement for nonspecific T or B cell mitogens. Eur J Immunol (1973) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
Role of C'3 and Fc receptors in B-lymphocyte activation. J Exp Med (1975) 1.30
A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother (1985) 1.29
Induction of autoantibodies to red blood cells by polyclonal B-cell activators. Nature (1976) 1.26
Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3. Eur J Immunol (1973) 1.26
Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity. Cell Immunol (1975) 1.26
Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells. Eur J Immunol (1972) 1.26
Immunocyte triggering. Cell Immunol (1970) 1.24
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
Differential effect of heterologous anti-lymphocyte serum on antibody-producing cells and antigen-sensitive cells. J Immunol (1968) 1.22
The role of adherent cells in the immune response. Fibroblasts and products released by fibroblasts and peritoneal cells can substitute for adherent cells. Scand J Immunol (1976) 1.21
The polyclonal B-cell-activating property of protein A is not due to its interaction with the FC part of immunoglobulin receptors. Scand J Immunol (1977) 1.19
HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction. Cell Immunol (1981) 1.19
Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis. J Immunol (1968) 1.19
Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE. Eur J Immunol (1988) 1.17
Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation. J Immunol Methods (1989) 1.14
Polyclonal B-cell activators induce immunological response to autologous serum proteins. Cell Immunol (1977) 1.13
Induction of CD43 expression during activation and terminal differentiation of human B cells. Scand J Immunol (1988) 1.13
Immunological unresponsiveness to native dextran B512 in young animals of dextran high responder strains is due to lack of Ig receptors expression. Evidence for a nonrandom expression of V-genes. J Exp Med (1978) 1.10
Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40. J Immunol (1989) 1.08
Reconstitution of immunocompetence in B cells by addition of concanavalin A or concanavalin A-treated thymus cells. Clin Exp Immunol (1973) 1.08
In vitro detection of transplantation immunity: the inhibition of migration of immune spleen cells and peripheral blood leukocytes by specific antigen. J Immunol (1970) 1.08
The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction. Immunogenetics (1982) 1.07
The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine (2005) 1.06
Induction of immunological tolerance requires that the B cells can respond to the polyclonal B-cell-activating properties of the thymus-independent antigens. J Exp Med (1977) 1.06
Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunology (1999) 1.04
Reversibility of high dose unresponsiveness to concanavalin A in thymus lymphocytes. Immunology (1972) 1.04
Inhibition of in vitro immune responses by a fraction from seminal plasma. Scand J Immunol (1976) 1.03
Irreversible immunological tolerance to thymus-independent antigens is restricted to the clone of B cells having both Ig and PBA receptors for the tolerogen. Scand J Immunol (1978) 1.03
In vitro correlates of transplantation immunity: the release of substances by immune lymphocytes confronted with specific antigens. Surgery (1969) 1.03
Release of migration inhibitory factors from immune rat lymphocytes confronted with histocompatibility antigens. Nature (1969) 1.02
Reactivity of human lymphocytes to aggregated and nonaggregated PPD-tuberculin. Cell Immunol (1972) 1.01
Immune response to haptenated syngeneic and allogeneic lymphocytes. I. Restrictions for B cell activation by haptenated lymphocytes and specificity of the antibodies generated. Scand J Immunol (1978) 1.00
Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB x NZW)F1 hybrid. Clin Immunol Immunopathol (1992) 1.00
Fractionation of immunocompetent spleen cells by albumin density gradient centrifugation. Immunology (1970) 0.99
Quantitation of the number of mitogen molecules activating DNA synthesis in T and B lymphocytes. Clin Exp Immunol (1973) 0.98
Heterologous antilymphocyte serum: differential effect on antigen-sensitive and antibody-producing cells. Surgery (1968) 0.98
Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod (2012) 0.97
Effect of PPD on the specific immune response to heterologous red cells in vitro. J Immunol (1974) 0.97
Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5. Mol Cell Endocrinol (2001) 0.97
The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96
Antigen-induced suppression of the in vitro lymphocyte response to different antigens and mitogens. Immunology (1972) 0.96
Expression of CD40 and CD43 during activation of human B lymphocytes. Scand J Immunol (1991) 0.95
Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Int Immunol (1999) 0.95
Mechanism of b-lymphocyte activation: failure to obtain evidence of a direct role of the Ig receptors in the triggering process. Scand J Immunol (1975) 0.95
Biologic properties of 19 S and 7 S mouse isoantibodies directed against isoantigens of the H-2 system. J Immunol (1966) 0.94